This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third lifesciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The third fund is now closed.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
As Chief Medical and Scientific Officer at Click Therapeutics and a Board Director at SpineThera, he spearheads AI-enabled clinical development and drug-delivery platforms. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled DrugDelivery in Uveal Melanoma Liver Metastases TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of … Continue reading →
The team also learned about the FDA approval of Genentech’s new ocular implant drugdelivery system, called Susvimo, for the treatment of neovascular, or wet, age-related macular degeneration (nAMD). Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer.
Employee retention and motivation is a challenge that all lifescience companies face. Lifescience companies often have to follow a complex regulatory framework that is associated with high risks, which is why maintaining corporate compliance is essential. Training and Development Opportunities.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. As it establishes these new operations, SHL Medical will be welcomed into a growing community of lifesciences companies expanding in and around Charleston.
Hayley Crowe is executive vice president and general manager of Ecolabâs Global LifeSciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses.
This extension will further help connect life-science innovators in Victoria to accelerate their healthcare solutions across the globe,” said Stacy Feld, Regional Head, Johnson & Johnson Innovation LLC, West North America, Australia & New Zealand.
When combined with mRNA therapeutic molecules developed by LG Chem, the pre-made drugdelivery formulation helps to simplify and improve the combination process. This is expected to shorten the development time of new drugs and to support personalised treatments.
A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.
“By offering all-in-one solutions, including drugdelivery connected devices, digital therapeutics, and care services, we aim to reduce existing gaps in healthcare by empowering patients, improving treatment adherence, and strengthening the patient and care team relationship,” said Touya.
In this interview, Xtalks spoke with two industry experts from Alira Health , Giulia Pierini , Principal of Patient Engagement, and Eduardo Perez-Guagnelli , PhD, Patient-Centric Co-Design Lead, about how lifesciences companies can adopt patient-centric co-design in their product development.
XTALKS : Changes are Coming to Prefilled Injectable DrugDelivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10 am PDT) Register for this webinar today to learn more about the future of injectable drugdelivery systems and the impact of blow-fill-seal technology.
XTALKS WEBINAR: Changes are Coming to Prefilled Injectable DrugDelivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn more about the future of injectable drugdelivery systems and the impact of blow-fill-seal technology.
XTALKS WEBINAR: Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled DrugDelivery Platforms Live and On-Demand: Thursday, February 27, 2025, at 1pm EST (10am PST) Register for this free webinar to learn critical considerations for improving global vaccine and healthcare delivery and outcomes.
The rankings are based on each companys ability to tackle critical challenges from drugdelivery and diagnostics to personalized therapies using cutting-edge science. Here we spotlight the top 20 most innovative pharma and biotech companies of 2025 from their 2025 list that are transforming health care.
XTALKS WEBINAR: DrugDelivery — Evaluating Off-The-Shelf and Novel DrugDelivery Solutions Live and On-Demand: Tuesday, July 11, 2023, at 1pm EDT (10am PDT) Register for this free webinar to learn about important tradeoffs when considering an off-the-shelf (OTS) drugdelivery platform vs. novel development.
Sanofi has agreed a deal with lifesciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drugdelivery specialist Enable Injections to develop the subcutaneous formulation.
One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.
The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on lifesciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.
Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers. The high concentration of scientists who face similar challenges makes this Summit so essential to the development of the field.
Whether you are a director, manager or hold a C-suite role within a pharma, biotech, medical device or lifescience organization, it is important to understand which leadership styles are currently gaining much influence in the industry. Visionary Leadership. A visionary sees what no one else can see especially in the present time.
Highly experienced lifesciences executive that brings large pharma and biotech experience. John will be joining the Board as the representative for Oxford Sciences Innovation (OSI), one of the Company’s major shareholders. OXFORD, England , Jan.
The lifesciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.
Related: Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer. Vuity’s formula is fast-acting, working as quickly as 15 minutes after administration and lasting for up to six hours. Importantly, it improves near and intermediate vision without affecting distance vision.
Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drugdelivery, administration and even in pill identification and prevention of counterfeiting.
Drug-eluting stents (DES): DES reduce the incidence of restenosis and are coated with drugs that inhibit scar tissue growth. DCBs: DCBs, such as the Agent DCB, combine mechanical widening of the artery with drugdelivery to the vessel wall to prevent cell proliferation.
LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab).
CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Vektor will begin planning and development work for the incorporation of various psychedelic compounds into its drug formulations.
Ocrevus Zunovo uses Halozyme Therapeutics’ Enhanze drugdelivery technology , which enhances absorption by temporarily increasing the permeability of the subcutaneous tissue. The enzyme rHuPH20 enables rapid dispersion of the drug into the bloodstream.
The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.
Amazon Pharmacy’s growing initiatives in the space, including RxPass and its prescription delivery and price-comparison site through Amazon PillPack, will be posing a threat to traditional drugstore giants like CVS Health Corp (CVS.N) and Walgreens Boots Alliance Inc (WBA.O).
CorpCann is a Norwegian-based international investment and consulting firm focused on European and North American opportunities in the lifescience, nutraceutical, aquaculture and energy industries. XPhyto is also pleased to announce a strategic European advisor engagement with CorpCann AS (“CorpCann”).
Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drugdelivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0
As a bioscience accelerator at the leading-edge of the lifescience industry, XPhyto will target growth through commercialization of existing products and focused investment in impact driven innovation with the potential for extreme value creation. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.
Dr. Bryan began his career at Schering-Plough, engaging in formulation and drugdelivery. Bryan says he was particularly drawn to the early-stage data from Revolo Biotherapeutics’ ‘1104 and ‘1805 therapeutic assets, which showed promise in various therapeutic avenues.
This innovative formulation uses Halozyme’s Enhanze drugdelivery technology, facilitating the subcutaneous administration of biologics. Vyvgart Hytrulo is a subcutaneous formulation that combines efgartigimod alfa, a human IgG1 antibody fragment, and recombinant human hyaluronidase PH20.
Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drugdelivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry.
Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. AstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma Treatment. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
Additionally, a collaboration with NurExone is creating an intranasal delivery system for exosome-based therapies targeting spinal cord injuries, with potential expansion into other neurological uses. Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drugdelivery innovation.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content